Remove Food Remove Networking Remove Pharmaceutical manufacturing
article thumbnail

Methods for strain comparison and differentiation of environmental isolates

European Pharmaceutical Review

NCIMB Ltd provides microbial identification services and curates The National Collection of Industrial, Food and Marine Bacteria – one of the culture collections that makes up the UK Biological Resource Centre Network.

article thumbnail

European authorities recognised for leading medicine regulatory oversight

European Pharmaceutical Review

WHO confirmed that the newly approved WLAs include: The European Medicines Regulatory Network (EMRN), which is made up of the European Commission (EC), the European Medicines Agency (EMA) and the medicines regulatory authorities of 30 countries.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Strengthening and transforming the pharmaceutical supply chain

European Pharmaceutical Review

Manufacturing delays and capacity issues that continue to impact the pharmaceutical supply chain have led to medicine shortages around the globe; an issue that has been exacerbated further by geopolitical events, the energy crisis and rising inflation. Globalisation and supply chain complexity are a factor.

article thumbnail

Strategies for Combination Therapy in Oncology: Part One – Business as Usual

PM360

Combination Therapy in Oncology Combination therapies comprising two or more therapeutic agents have become a cornerstone of oncology management and are increasingly a development focus for the pharmaceutical industry. Food and Drug Administration (FDA) oncology approvals were for drugs used in combination. JAMA Network Open 5 , no.

article thumbnail

Diversity and inclusion in oncology clinical trials

Clarify Health

Food and Drug Administration (FDA) released guidance entitled, Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry. J National Comprehensive Cancer Network. To advance equity in clinical research, the U.S. 2019;17(11):1309-1316. doi:10.6004/jnccn.2019.7321

article thumbnail

Ep. 002 – John Mack Podcast Transcript

Pharma Marketing Network

So I would expect we’re going to find the same type of welcoming environment, maybe even more so with the pharma marketing network brand behind us. If you’re a pharmaceutical company or if you’re an agency or even a consultant. 002 – John Mack Podcast Transcript appeared first on Pharma Marketing Network.

Pharma 52
article thumbnail

New IFPMA and EFPIA guidance on use of social media by the pharmaceutical industry

pharmaphorum

Digital channels are defined as “ platforms for electronic communication through transmission of digital content over the internet or computer networks. It identifies the most used social media and digital channels and sets out specific guidance for each. Digital Channels include, but are not limited to, social media ”.

Media 98